Sunday, August 30, 2020 4:23:46 PM
I'm trying not to get too excited about this info, trying to stay calm, but I'm seeing a subtle hint from the Proponents on page 33, 8.2... last paragraph.
Please read the "VIII. FEASIBILITY AND LIQUIDATION ANALYSES,"
pages 32-33 CAREFULLY, as if you were one of the Creditors for BRTXQ.
VIII. FEASIBILITY AND LIQUIDATION ANALYSES
Which PLAN would you logically choose? No Brainer, right??
"8.2 Best Interests of Creditors and Comparison with Chapter 7 Liquidation"
As a condition to confirmation of the Plan, Section 1129(a)(7)(A)(ii) of the Bankruptcy
Code requires that each holder of a claim or an interest in an impaired Class of Claims or Equity
Interests must either accept the Plan or receive or retain at least the amount or value it would
receive if the Debtor were liquidated under chapter 7 of the Bankruptcy Code on the Effective
Date of the Plan.
Attached as Exhibit D is a liquidation analysis for the Debtor. If the Plan is not
confirmed, the Debtor’s case would be converted to a chapter 7 case. As is demonstrated by the
liquidation analysis, in a chapter 7 case the liquidation of the Debtor’s assets would not generate
sufficient funds to pay secured claims in full, much less pay a dividend to Administrative
Claims, Priority Claims or General Unsecured Claims.
Here's where it gets really GOOD!!!!
"In contrast, the Plan will provide for the payment in full of all secured claims,
Administrative Claims and Priority Claims, and will distribute Common Stock or convertible
notes and warrants to the holders of Allowed General Unsecured Claims and Allowed Equity
Interests. The Proponents have not projected the value of such Common Stock on the Effective
Date, but if the Reorganized Debtor can successfully develop its technology, the Common Stock
may increase in value. Since the Petition Date, the Debtor’s stock has been trading at between
$0.0001 and $0.0002 per share. If the Debtor’s share price continues to trade in that range after
the Effective Date, a creditor electing to receive 100 shares per each $1.00 of unsecured debt
would receive value of between $0.01 and $0.02 on that debt. Naturally, in the event that share
price increases because the marketplace determines that the Debtor’s value has increased prior to
confirmation of the Plan or will increase upon exit from bankruptcy under a confirmed Plan,
such value may increase to the benefit of all shareholders, including those creditors receiving
shares in exchange for debt. In any event, confirmation of the Plan will result in a greater return
to unsecured creditors than might be realized if this case were converted to a case under chapter
7 of the Bankruptcy Code."
All educated and reasonable comments welcome on what the Proponents are saying between the lines here. Thank you for any serious intelligent feedback!
GTLA... GO BRTXQ!!!
Recent BRTX News
- BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference • GlobeNewswire Inc. • 10/03/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:33:16 PM
- BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs • GlobeNewswire Inc. • 09/19/2024 10:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:30:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:11:03 PM
- BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/08/2024 08:23:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:47:26 PM
- BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine • GlobeNewswire Inc. • 07/23/2024 11:10:00 AM
- BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/27/2024 11:40:00 AM
- BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 06/17/2024 11:05:00 AM
- Shares of Biotech MicroCap Rip on Licensing Talks • AllPennyStocks.com • 06/13/2024 03:40:00 PM
- BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/11/2024 08:28:30 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/11/2024 08:23:50 PM
- BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 12:50:00 PM
- BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice • GlobeNewswire Inc. • 05/24/2024 11:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:51:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:45:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:17:17 PM
- BioRestorative Therapies Provides First Quarter 2024 Business Update • GlobeNewswire Inc. • 05/14/2024 08:10:00 PM
- BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM